Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
09/09/2009 | EP2097372A1 Process for the preparation of memantine and its hydrochloric acid salt form |
09/09/2009 | EP2097371A2 Benzocycloheptyl analogs having sphingosine 1-phosphate receptor activity |
09/09/2009 | EP2097109A2 Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production |
09/09/2009 | EP2097083A2 Dosage forms and co-administration of an opioid agonist and an opioid antagonist |
09/09/2009 | EP2097079A2 Modulation of prostaglandin/cyclooxygenase metabolic pathways |
09/09/2009 | EP2097070A1 Robust sustained release formulations of oxymorphone and methods of use thereof |
09/09/2009 | EP2097069A1 Robust sustained release formulations of oxymorphone |
09/09/2009 | EP2096927A2 Therapeutic compositions and methods of treatment with capsianoside-type compounds |
09/09/2009 | EP1957488B1 3-amino-2-arylpropyl azaindoles and uses thereof |
09/09/2009 | EP1838677B1 Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride |
09/09/2009 | EP1732917B8 Selected cgrp antagonists, methods for the production thereof and their use as medicaments |
09/09/2009 | EP1515947B1 Fluorinated cycloalkyl-derivatised benzoylguanidines and their use as a medicament |
09/09/2009 | EP1509621B1 Diagnostic of alzheimer's disease by analysis of il-10 gene polymorphisms |
09/09/2009 | EP1474150B1 Use of 2-alkoxyphenyl-substituted imidazotriazinones for the treatment of cardiac insufficiency |
09/09/2009 | EP1446733B1 Glycosylphosphatidylinositol containing polypeptides |
09/09/2009 | EP1392326B1 Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
09/09/2009 | EP0939659B1 Device for transdermal electrotransport delivery of fentanyl and sufentanil |
09/09/2009 | EP0861261B1 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
09/09/2009 | EP0813545B1 Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon |
09/09/2009 | CN101528209A Oleanane triterpene saponin compounds which are effective on treatment of dementia and mild cognitive impairment(MCI), and improvement of cognitive function |
09/09/2009 | CN101525570A Glossy ganoderma-ginseng sedative wine |
09/09/2009 | CN101525384A A bispecific antibody and the making method and the application thereof |
09/09/2009 | CN101525333A Synthesis method of metixene hydrochloride |
09/09/2009 | CN101524519A Chinese materia medica preparation for treating insomnia and preparation method thereof |
09/09/2009 | CN101524513A Health pillow drug core |
09/09/2009 | CN101524493A Multifunctional Chinese medicine honeyed pill |
09/09/2009 | CN101524394A Quezui tea preparation and application thereof |
09/09/2009 | CN101524385A Preparation process for ginseng extract |
09/09/2009 | CN101524384A Preparation process for manyprickle acathopanax root extract |
09/09/2009 | CN101524381A Ginkgo pollen extractive and preparation method and application thereof |
09/09/2009 | CN101524377A Composite of wall-breaking lucidum spore powder and cyclodextrin and preparation method thereof |
09/09/2009 | CN101524375A Wet-process wall breaking method of lucidum spore powder |
09/09/2009 | CN101524370A Production technology of pig brain protolysate |
09/09/2009 | CN101524361A Process for preparing adenosine analogue and its application |
09/09/2009 | CN101524350A Application of N-methyl-N-benzyl-3-chloro-6-methoxyl-benzothiophene -2-formamide |
09/09/2009 | CN101524346A Application of conjugated linoleic acid (CLA) in preparing drugs for treating Alzheimer disease |
09/09/2009 | CN101524345A Medicine composition without any excipients and preparation process thereof |
09/09/2009 | CN101524342A Use of injection sodium vedproate in psychiatric department treatment |
09/09/2009 | CN101524339A Fentanyl patch |
09/09/2009 | CN101524337A Prolonged release mucosal bioadhesive system |
09/09/2009 | CN101524232A Concave medicine pillow |
09/09/2009 | CN101524227A Production method of silk quilt for treating insomnia and improving sleep quality |
09/09/2009 | CN101524226A Production method of silk quilt for treating neurasthenia |
09/09/2009 | CN101524190A Disease preventing and curing medicinal mouth-muffle and medicinal composite |
09/09/2009 | CN100537571C Imidazo[1,2-a]pyrazin-8-ylamines, method of making and method of use thereof |
09/09/2009 | CN100537546C Novel alkansulfonamides as endothelin antagonists |
09/09/2009 | CN100537527C Aryl and biaryl compounds having MCH modulatory activity |
09/09/2009 | CN100537520C N-bridged selective androgen receptor modulators and methods of use thereof |
09/09/2009 | CN100536919C Interferon antagon and usage of Flt3L antagon |
09/09/2009 | CN100536915C 神经毒素植入物 Neurotoxin implant |
09/09/2009 | CN100536857C Soft capsule of extractive from leaves of persimmon and self-emulsifying system for releasing drug |
09/09/2009 | CN100536851C Phospholipid derivatives of valproic acid and mixtures thereof |
09/09/2009 | CN100536839C Urea derivatives as integrin alpha 4 antagonists |
09/08/2009 | US7585974 Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, their preparation and their therapeutic application |
09/08/2009 | US7585880 Phenylpropanoic acid derivatives |
09/08/2009 | US7585878 2-[(2,5-dimethylpyrrolidin-1-yl)methyl]-N-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)biphenyl-4-carboxamide; capsaicin receptor VR1 inhibitory activity; inflammatory pain and neurogenic pain, migraine, cluster headache, bladder diseases including overactive bladder |
09/08/2009 | US7585876 Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
09/08/2009 | US7585873 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands |
09/08/2009 | US7585860 Substituted oxazolidinones and their use in the field of blood coagulation |
09/08/2009 | US7585853 Compounds having selective inhibiting effect at GSK3 |
09/08/2009 | US7585507 Nucleic acid molecules and polypeptides for immune modulation |
09/08/2009 | US7585502 Antigen binding fragment binds to denatured polypeptide which chemoattracts peripheral blood monocytes or T-cells; immunization |
09/08/2009 | CA2522813C 2-alkynyl-and 2-alkenyl-pyrazolo-¬4,3-e|-1,2,4-triazolo-¬1,5-c|-pyrimidine adenosine a2a receptor antagonists |
09/08/2009 | CA2478066C Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting |
09/08/2009 | CA2468833C (20s)-1.alpha.-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses |
09/08/2009 | CA2463598C Imidazo (4,3-e)-1,2,4-triazolo(1,5-c) pyrimidines as adenosine a2a receptor antagonists |
09/08/2009 | CA2442210C Aryl oxime-piperazines useful as ccr5 antagonists |
09/08/2009 | CA2417758C Use of the combination of nicotinic acid or derivatives with riboflavin in the manufacture of a medicament for the treatment of primary headaches |
09/08/2009 | CA2366820C Novel [(2-substituted-5 -[3-thienyl) -benzyl]-[2- ([2-isopropoxy-5-fluoro] -phenoxy) -ethyl] -amine derivatives, method for the production and use thereof as medicaments |
09/08/2009 | CA2360360C Piperidyl benzamide compounds, composition containing same and their use thereof |
09/08/2009 | CA2348319C Cyclohexenol derivative and medicament containing the same |
09/08/2009 | CA2342739C Azetidine derivatives, preparation and medicines containing them |
09/08/2009 | CA2341010C Process for the manufacture of ethanesulfonyl-piperidine derivatives |
09/08/2009 | CA2335623C Aminoiminoquinone and aminoquinine alkaloid compounds as capase inhibitors |
09/08/2009 | CA2329636C Riluzole and levodopa combinations for treating parkinson's disease |
09/08/2009 | CA2292017C Substituted cycloheptenes, their preparation and use |
09/08/2009 | CA2290745C Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
09/03/2009 | WO2009108804A2 Steroid analogues for neuroprotection |
09/03/2009 | WO2009108766A1 Gamma secretase modulators for the treatment of alzheimer ' s disease |
09/03/2009 | WO2009108657A2 Heteroaryl derivatives as cftr modulators |
09/03/2009 | WO2009108632A1 Compositions and methods for using stromal cells to enhance treatment of central nervous system injuries |
09/03/2009 | WO2009108376A2 Contrast agents for applications including perfusion imaging |
09/03/2009 | WO2009108117A1 Muscarinic receptor agonists, compositions, methods of treatment thereof, and processes for preparation thereof 177 |
09/03/2009 | WO2009107478A1 Adhesive skin patch and packaged product |
09/03/2009 | WO2009107401A1 Kit, composition, product or medicament for treating cognitive impairment |
09/03/2009 | WO2009107391A1 Compound having 6-membered aromatic ring |
09/03/2009 | WO2009107387A1 2-oxochromene derivative |
09/03/2009 | WO2009106982A1 Indazole derivatives |
09/03/2009 | WO2009106980A2 Indazole derivatives |
09/03/2009 | WO2009106855A1 NOVEL USES OF VEGFxxxB |
09/03/2009 | WO2009106831A2 Pharmaceutical composition |
09/03/2009 | WO2009106769A1 5-[1'-(decahydro-7-hydroxy-1,1,3a,7-tetramethyl-1h-cyclopropa[a]naphtalen-4-yl)-3'-methylbutyl]-2,4,6-trihydroxy-1,3-benzenedicarboxaldehyde used as drugs |
09/03/2009 | WO2009106752A2 Derivatives of 2-heteroaroyl-imidazol[1,2-a]pyridine, preparation thereof and therapeutic application thereof |
09/03/2009 | WO2009106751A2 Derivatives of n-heterocyclic-6-heterocyclic-imidazo[l,2- a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
09/03/2009 | WO2009106749A2 Derivatives of n-heterocyclic-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
09/03/2009 | WO2009106748A2 Derivatives of n-phenyl-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
09/03/2009 | WO2009106708A2 Azetidine derivatives, their preparation and their application in therapy |
09/03/2009 | WO2009106574A2 Combinations for treating hiv-associated pain |
09/03/2009 | WO2009106534A1 Novel heterocyclic carboxamides as m1 agonists |
09/03/2009 | WO2009106516A1 Compositions, kits and methods for a titration schedule for pardoprunox compounds |